When was Protembis Gmbh incorporated?

Protembis Gmbh was incorporated on May 21, 2017 and its current company status is Active.

What is the Corporate Identification Number (CIN) of Protembis Gmbh?

Protembis Gmbh's Corporate Identification Number (CIN) is HRB21218.

What is the registered address of Protembis Gmbh?

The registered address of Protembis Gmbh is Aachen.

What is the latest employee count at Protembis Gmbh?

As of Dec 31, 2018, the latest employee count at Protembis Gmbh is 3, reflecting a 0% year-over-year growth in headcount.

Protembis Gmbh - 2026 Company Profile

Name: Protembis Gmbh
Brand: Protembis Gmbh
Price: 1.69 EUR

Protembis Gmbh is a Private Limited Company and was incorporated on May 21, 2017 in Germany. Its corporate identification number is (CIN) HRB21218 and its current status is Active.

Key Metrics

CIN

HRB21218

Current Status

Active

Entity Type

Private Limited Company

Date Of Incorporation

May 21, 2017

Latest Employee Count

3 as on Dec 31, 2018

Registered Address: Aachen

There is one brand associated with Protembis Gmbh which include Protembis .

Name	Short Description	Founded Year	Location	Current Stage
Protembis	Manufacturer of cerebral protection device	2013	Germany	Public

View more details on Protembis Gmbh's profile

Protembis is the only brand associated with Protembis Gmbh, and here are its Top 10 competitors ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Synaptive Medical 2012, Mississauga (Canada), Series C	Planning and imaging solutions for neurosurgery	$76.8M	General Atlantic, Sensegain Capital & 10 others	64/100
2nd	Emboline 2011, Santa Cruz (United States), Series D	Developer of an aortic embolic protection device	$102M	SV Tech Ventures, Matrix Capital Management ... & 9 others	56/100
3rd	Claret Medical 2009, Santa Rosa (United States), Acquired	Developer of cerebral vascular protection systems for use during endovascular procedures	$51.4M	Sante Ventures, Lightstone Ventures & 6 others	53/100
4th	Protembis 2013, Aachen (Germany), Public	Manufacturer of cerebral protection device	$45.2M	Coparion, Segulah Medical Acceleration ... & 19 others	47/100
5th	Filterlex Medical 2015, Tel Aviv (Israel), Series B	Developer of an embolic protection device	$16.9M	Medical Technology Venture Partners, Europa ... & 4 others	46/100
6th	Transverse Medical 2011, Golden (United States), Series B	Developer of a device to prevent stroke during transcatheter aortic valve replacement heart procedures	$26.8M	Grant Park Ventures, Flight Partners Capital	40/100
7th	NeuraMedica 2014, Oregon City (United States), Seed	Developer of a dural clip that helps in durotomy and orthopedic spinal closures	$1.85M	NIH, ONAMI & 1 others	35/100
8th	Invictus Medical 2010, San Antonio (United States), Series A	Innovating NICU environments, improving newborn lives through noise reduction technology	$8.93M	-	35/100
9th	Keystone Heart 2004, Tampa (United States), Acquired	Embolic cerebral protection devices	$14M	Western Technology Investment, Orbimed	32/100
10th	Embrella Cardiovascular 2007, Malvern (United States), Acquired	Cardiovascular procedure protection	$6.7M	BioStar Capital, 415 CAPITAL & 2 others	32/100